INLX vs MSFT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits severe financial weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' health category. Despite a strong gross margin of 66.05%, the business is struggling with stagnant revenue growth (1.00% YoY) and negative profitability (ROE -17.01%). The technical trend is completely bearish (0/100), and the stock has lost over 53% of its value in the last year. With a Forward P/E of 116.67 and no meaningful growth catalysts, the current valuation is difficult to justify.
Microsoft exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and stability. While the stock trades at a significant premium to its Graham Number ($138.23), it remains below its growth-based intrinsic value of $476.13, suggesting reasonable upside. Exceptional earnings growth (59.8% YoY) and elite profit margins (39.04%) outweigh current bearish technical trends and insider selling. The company's consistent track record of beating earnings estimates over 25 quarters reinforces a strong long-term outlook.
Compare Another Pair
Related Comparisons
INLX vs MSFT: Head-to-Head Comparison
This page compares Intellinetics, Inc. (INLX) and Microsoft Corporation (MSFT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.